Cost-Effectiveness of HIV Testing and Treatment in the United States
Walensky RP, Freedberg KA, Weinstein MC, Paltiel AD. Cost-Effectiveness of HIV Testing and Treatment in the United States. Clinical Infectious Diseases 2007, 45: s248-s254. PMID: 18190295, PMCID: PMC2365915, DOI: 10.1086/522546.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAIDS SerodiagnosisCost-Benefit AnalysisDiagnostic ServicesHIV InfectionsHumansMiddle AgedUnited StatesConceptsHIV testingVoluntary human immunodeficiency virus (HIV) testingHuman immunodeficiency virus (HIV) testingRoutine HIV testingVoluntary HIV testingLower cost-effectiveness ratioCost-effectiveness ratioCost-effectiveness studiesHealth care settingsPublic health importanceHealth care interventionsCost-effectiveness analysisImmunodeficiency syndromeRisk factorsCare interventionsUS CentersCare settingsVirus testingHealth effectivenessHealth importanceDisease controlRecent evidenceHIVNew guidelinesUnited States